Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CUE
CUE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CUE News
Cue Biopharma Grants Equity Awards to New Employees
3d ago
Newsfilter
Market Pauses After AI and Mega-Cap Tech Rally
May 01 2026
stocktwits
CUE Biopharma Stock Soars 56.2% in Premarket Trading Following New CEO Announcement, Licensing Deal, and $30 Million Private Placement
May 01 2026
moomoo
Cue Biopharma Secures $30 Million Financing and Appoints New CEO
May 01 2026
NASDAQ.COM
Cue Biopharma Secures $30 Million Financing and New CEO
May 01 2026
stocktwits
Cue Biopharma Announces 1-for-30 Reverse Stock Split
Apr 22 2026
seekingalpha
Cue Biopharma Announces 1-for-30 Reverse Stock Split
Apr 22 2026
Newsfilter
Cue Biopharma and Boehringer Ingelheim Announce Strategic Collaboration
Apr 10 2026
stocktwits
Cue Biopharma Secures $7.5 Million Milestone Payment
Apr 09 2026
NASDAQ.COM
CUE BIOPHARMA INC ANTICIPATES $7.5 MILLION PAYMENT IN MAY 2026
Apr 08 2026
moomoo
Cue Biopharma CEO Resignation Leads to 8% Stock Drop
Mar 28 2026
stocktwits
CUE Stock Declines Following CEO's Departure After Only Six Months
Mar 28 2026
stocktwits
Cue Biopharma Appoints New Interim CEO
Mar 27 2026
seekingalpha
Cue Biopharma Appoints New CEO Amid Leadership Transition
Mar 27 2026
Newsfilter
Cue Biopharma Reports Strong Q4 Earnings with Significant Revenue Growth
Mar 17 2026
seekingalpha
Cue Biopharma Reports Strong Q4 and Full-Year 2025 Financial Results
Mar 17 2026
NASDAQ.COM
Show More News
